Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction

Hypertension Research

Volumn 27, Issue 10, 2004, Pages 717-722

  Ding, Wen Hui ^b   Chu, Song Yun ^b   Jiang, Hong Feng ^b   Cai, Da Yong ^b   Pang, Yong Zheng ^b   Tang, Chao Shu ^a   Qi, Yong Fen ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Coupling factor 6; peptide

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; CREATINE KINASE; LOW DENSITY LIPOPROTEIN; MITOCHONDRIAL COUPLING FACTOR 6; NITRIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COUPLING FACTOR; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MYOCARDIAL INFARCTION; OSMOLAR CONCENTRATION; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; PHOSPHOTRANSFERASES (NITROGENOUS GROUP ACCEPTOR); RISK FACTORS;

EID: 11044238420     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.717     Document Type: Article

References (13)

1. Ding WH, Wu FX, Ma HF, Tang CS: Dynamic changes and significance of plasma endothelin in patients with acute myocardial infarction during reperfusion. J Chin Circ 1998; 13: 147-148.
2. Shi LB, Ding WH, Yang JJ: Alterations and significance of urotensin II in patients with ischemic diseases. J Chin Med 2001; 40: 634-635.
3. Cao J, Zhang JH, Wang XH: Changes and its protective role of plasma adrenomedullin in patients with ischemia/reperfusion injury. J Chin Med 2000; 80: 261-264.
4. Ding WH, Zhang JH, Tang CS: Calcitonine gene-related peptides and fibrinolysis. J Chin Cardiovasc Dis 1993; 21: 80-82.
5. Osanai T, Kamada T, Fujiwara N, et al: A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem 1998; 273: 31778-31783.
6. +-ATP synthase in mitochondria. Biochem Biophys Res Commun 1991; 178: 793-799.
7. Osanai T, Okada S, Sirato K, et al: Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation 2001; 104: 3132-3136.
8. Kato J, Kitamura K, Uemura T, et al: Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002; 25: 887-892.
9. Osanai T, Tanaka M, Kamada T, et al: Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest 2001; 108: 1023-1030.
10. Chang JK, Scruggs P, Yang J, et al: Total synthesis of human and rat coupling factor-6 amide and pressor effects in the rat. Regul Pept 2003; 113: 63-69.
11. Osanai T, Sasaki S, Kamada T, et al: Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. J Hypertens 2003; 21: 2323-2328.
12. Osanai T, Nakamura M, Sasaki S, et al: Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 2003; 64: 2291-2297.
13. Veeravalli KK, Akula A: Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction Pharmacol Res 2004; 49: 23-29.